Medical trial workflow platform OneStudyTeam, a Reify Well being firm, has laid off 160 workers, or roughly 25% of its workforce.
“We are able to verify that we made the very troublesome choice to let a few of our crew members go. Every individual performed a job in constructing OneStudyTeam, and we’re grateful for his or her contribution to our mission of accelerating the event of life saving therapies for sufferers. We concluded that we have to restructure our crew going into 2023 to streamline operations after a interval of extraordinarily speedy development and hiring,” an organization spokesperson advised MobiHealthNews in an e mail.
THE LARGER TREND
In November, OneStudyTeam introduced a partnership with New York-based Antidote Applied sciences to supply one platform for scientific trial sponsors, websites and members, which might make the most of OneStudyTeam’s cloud-based software program StudyTeam and Antidote’s affected person engagement platform.
In April, OneStudyTeam’s guardian firm Reify garnered $220 million in Sequence D funding, boosting the corporate’s valuation to $4.8 billion.
That spherical got here lower than a yr after the corporate raised $220 million in Sequence C funding. The corporate additionally introduced in $30 million in Sequence B financing in 2020.
#OneStudyTeam #lays #quarter #workforce
- Donate withBitcoin
- Donate withDogecoin
- Donate withLitecoin
- Donate withTether
- Donate withBinance coin
- Donate withTron
- Donate withBitcoin cash
- Donate withDash